THE PRIMER
SCIENCE MADE SIMPLE
Stay Updated! Subscribe to The Primer
Share
Cancer’s Community Drama: The Tumor Microenvironment Explained
Cancer isn’t just a collection of rebellious cells—it’s a full-blown ecosystem. The tumor microenvironment (TME) is the chaotic community where cancer cells thrive, manipulate their neighbors, and plot their next move to create more trouble. Understanding the TME is a...
Taking a Bite Out of Tooth Decay: Fluoride Explained
Utah just became the first U.S. state to ban mandatory fluoride in public drinking water, with a new law taking effect on May 7, 2025. Cities can still add it, but the state’s no longer calling the shots. Fluoride is like a suit of armor for teeth and rebar for your...
Gut to Glory: GLP-1 Weight Loss Explained
The buzziest weight loss drugs today—think Ozempic, Wegovy, and Mounjaro—weren’t discovered so much as stumbled upon. It turns out that scientists were trying to figure out diabetes, and instead, they found a way to slim us all down. Let’s dig in. What It Is GLP-1...
Tiny Code, Big Impact: mRNA Vaccines Explained
mRNA vaccines burst onto the global stage during COVID-19—but their real story is just getting started. These next-gen shots don’t just train your immune system—they’ve rewritten the playbook for how we fight disease. Let’s learn how these vaccines work and why this...
NIH Funding Explained
The National Institutes of Health (NIH) has been the quiet powerhouse fueling America’s biomedical research engine. With a hefty annual budget ($47 billion in 2025), NIH funds everything from basic biology to life-saving therapies, making it a critical player in...
Transgenic Mice Explained
Transgenic mice—genetically modified mice with added or deleted genes—are the unsung heroes of drug development. These tiny lab warriors help scientists understand diseases, test drugs, and even produce monoclonal antibodies used as medicines. If there’s a scientific...
Medicines that Glow: Radiopharmaceuticals Explained
Radiopharmaceuticals Explained
Small Patient Populations, Big Challenges: Rare Disease Explained
With over 7,000 rare diseases affecting more than 30 million Americans, these conditions—many of them genetic—often lack effective treatments.
Molecule to Marketplace: Pharmaceutical Commercialization Explained
Pharmaceutical commercialization is like the ultimate relay race: it takes groundbreaking science and sprints it across the finish line to improve lives.
Biotech’s Rising Star: Peptide Drugs Explained
These tiny proteins pack a therapeutic punch with precision and fewer side effects. Let’s take a closer look at peptides in this week’s Primer!
Biotech Primer is your go-to source for interactive training across the biotechnology, pharmaceutical, molecular diagnostics, and medical device sectors. Explore a range of in-depth biotech courses designed to deepen your understanding of key principles and applications in the field.